Skip to main content
Livermore
Livermore
ZHEN

PROCEPT BioRobotics Corp

PRCT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001588978

In the last 90 days, PROCEPT BioRobotics Corp insiders filed 1 open-market purchase and 3 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $1.24B in total; no superinvestor holds it.

Superinvestors holding PRCT, Q2 2026

See all superinvestors

No superinvestor reported holding PRCT in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of PRCT each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q3 2022

    0 superinvestors holding at quarter end

    Sold out
    Viking Global Investors, Duquesne Family Office

  2. Q2 2022

    2 superinvestors holding at quarter end

    Reduced
    Viking Global Investors (−57.8%), Duquesne Family Office (−96.5%)

  3. Q1 2022

    2 superinvestors holding at quarter end

    Reduced
    Viking Global Investors (−25.4%), Duquesne Family Office (−32.1%)

  4. Q4 2021

    2 superinvestors holding at quarter end

    Added
    Duquesne Family Office (+176.7%)

  5. Q3 2021

    2 superinvestors holding at quarter end

    New
    Viking Global Investors, Duquesne Family Office